Implementation of Routine Walking Speed Measurements in Older Veterans
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Office of Research and Development
About this trial
Walking speed is a powerful predictor of mortality and adverse health consequences (e.g. fall or hospitalization) in older adults. Knowledge of individuals' walking speed can provide unique insight into current physical function and need for healthcare services. Furthermore, walking speed is a modifiable risk factor such that early recognition of physical function decline allows for appropriate and timely intervention prior to the occurrence of adverse health events. Therefore, this proposal seeks to implement routine measures of walking speed into VHA primary care as a 'vital sign' to routinely monitor Veteran physical function and help guide provider referrals.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
VHA primary care clinics
Providers working in a VHA primary care clinic where FASTER is implemented
Nursing staff working in a VHA primary care clinic where FASTER is implemented
Veterans 60 years and older receiving care in a VHA primary care clinic where FASTER is implemented
Disqualifiers
None
Trial design
Design model
Crossover
Treatments tested in this trial
Usual Care
Other interventionDuring the Usual Care phase, participating clinics will continue with usual care with the addition that walking speed will be measured and recorded. Veterans and providers will be blinded to walking speed measurement so as to not influence care.
FASTER
Other interventionDuring the FASTER phase, walking speed will be measured during clinic visits, recorded in the medical record, and used by providers to guide care. An Action Toolkit will be provided with resources for providers to support informed care decisions based on Veterans' walking speeds.
Treatment groups
10,500 Participants
are divided into 2 treatment groupsGroup A: Usual CareActive comparator 1 intervention
Group B: FASTERExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Walking Speed
Time to complete 4-meter walk at usual speed converted to meters per second. Higher speed indicates better function.
Time frame
Change in walking speed before exposure and change in walking speed after exposure to FASTER intervention (up to 12 months).Secondary outcomes
1
Adverse Events (Injurious Falls)
Falls that result in a medical visit
Time frame
Start of usual care to end of implementation (anticipated 24 months).2
Adverse Events (Emergency Department Visits and Hospitalizations)
Emergency department visits and hospitalizations
Time frame
Start of usual care to end of implementation (anticipated 24 months).Other outcomes
1
RE-AIM Component: Reach
Proportion of visits with a walking speed measured out of all in-person primary care visits (Veterans ≥65 years of age)
Time frame
Start of usual care to end of implementation (anticipated 24 months).2
RE-AIM Component: Adoption (Providers)
Proportion of providers that state they will use walking speed information
Time frame
Start of implementation.3
RE-AIM Component: Adoption (Assessors)
Proportion of assessors that state they will measure walking speed
Time frame
Start of usual care.4
RE-AIM Component: Adoption (Clinics)
Proportion of clinics that state they will implement walking speed
Time frame
Start of usual care.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: